3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Uterine Cervical Neoplasms
2
Rectal Neoplasms
2
Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Prostate Cancer, Hereditary, 7
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Muscle Weakness
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Hypoxia
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Disease
1
Colonic Neoplasms
1
Astrocytoma
1
Anus Neoplasms
1
Interventions
Specimen Handling
9
Magnetic Resonance Spectroscopy
9
Cisplatin
5
Cetuximab
5
pembrolizumab
4
Platinum
4
Biopsy
4
1,2-diaminocyclohexaneplatinum II citrate
4
cemiplimab
3
Radiotherapy
3
Immunoglobulin G
3
Disulfides
3
(225)Ac-DOTA-c(RGDyK)
3
ipatasertib
2
Ultrasonography
2
Radiotherapy, Intensity-Modulated
2
Radiation
2
Nivolumab
2
Carboplatin
2
Bevacizumab
2
trastuzumab deruxtecan
1
temsirolimus
1
niraparib
1
merphos
1
durvalumab
1
dostarlimab
1
cabozantinib
1
brodalumab
1
atezolizumab
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
Magnetic Resonance Imaging
×
30 days
×
Clear all
No trials found.